Tamoxifen radiosensitization in human glioblastoma cell lines

Journal of Neurosurgery

Volumn 90, Issue 3, 1999, Pages 533-536

  Donson, Andrew M ^b   Weil, Michael D ^b   Foreman, Nicholas K ^a  

^a CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

Glioblastoma multiforme; Radiation therapy; Synergism; Tamoxifen

Indexed keywords

TAMOXIFEN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIZATION;

EID: 0032966745     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1999.90.3.0533     Document Type: Article

References (21)

1. Baltuch O, Shenouda G, Langleben A. et al: High dose tamoxifen in the treatment of recurrent high grade glioma: a report of clinical stabilization and tumour regression. Can J Neurol Sci 20:168-170, 1993
2. Cabot MC, Zhang Z, Cao H, et al: Tamoxifen activates cellular phospholipase C and D and elicits protein kinase C translocation. Int J Cancer 70:567-574, 1997
3. Chou TC, Motzer RJ, Tong Y, et al: Computerized quantitation of synergism and antagonism of taxol, topotecan and cisplatin against teratocarcinoma cell growth: a rational approach to clinical protocol design. J Natl Cancer Inst 86:1517-1524, 1994
4. Chou TC, Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27-55, 1984
5. Couldwell WT, Antel JP, Yong VW: Protein kinase C activity correlates with the growth rate of malignant human gliomas: Part II. Effects of glioblastoma mitogens and modulators of protein kinase C. Neurosurgery 31:717-724, 1992
6. Couldwell WT, Uhm JH, Antel JP, et al: Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery 29:880-887, 1991
7. Couldwell WT, Weiss MH, DeGiorgio CM, et al: Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 32:485-490, 1993
8. Horgan K, Cooke E, Hallett MB, et al: Inhibition of protein kinase C mediated signal transduction by tamoxifen. Importance for antitumor activity. Biochem Pharmacol 35:4463-4465, 1986
9. Leonard CE, Chan DC, Chou TC, et al: Paclitaxel enhanced in vitro radiosensitizer of squamous carcinoma cell lines of the head and neck. Cancer Res 56:5198-5204, 1996
10. Lerner LJ, Jordan VC: Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture. Cancer Res 50:4177-4189, 1990
11. Lien EA, Solheim E, Ueland PM: Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Res 51:4837-4844, 1991
12. McClay EF, Mastrangelo MJ, Bellet RE, et al: Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma. Cancer Treat Rep 71:465-469, 1987
13. Millward MJ, Lien EA, Robinson A, et al: High-dose (480 mg/ day) tamoxifen with etoposide: a study of a potential multi-drug resistance modulator. Oncology 51:79-83, 1994
14. O'Brian CA, Liskamp RM, Soloman DH, et al: Inhibition of protein kinase C by tamoxifen. Cancer Res 45:2462-2465, 1985
15. Pollack IF, Randall MS, Kristofik MP, et al: Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res 50:7134-7138, 1990
16. Rowlands MG, Parr IB, McCague R, et al: Variation of the inhibition of calmodulin-dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity. Biochem Pharmacol 40:283-289, 1990
17. Su HD, Mazzei GJ, Vogler WR, et al: Effects of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from rat brain and ovary. Biochem Pharmacol 34: 3649-3653, 1985
18. Sutherland RL, Murphy LC, Foo MS, et al: High-affinity antioestrogen binding site distinct from the oestrogen receptor. Nature 288:273-275, 1980
19. Terasima T, Tolmach LJ: X-ray sensitivity and DNA synthesis in synchronous populations of He La cells. Science 140: 490-492, 1963
20. Vertosick FT, Selker RG, Pollack IF, et al: The treatment of intracranial malignant gliomas using orally administered tamoxifen therapy: preliminary results in a series of "failed" patients. Neurosurgery 30:897-903, 1992
21. Zhang W, Yamada H, Sakai N, et al: Enhancement of radiosensitivity by tamoxifen in C6 glioma cells. Neurosurgery 31: 725-730, 1992